Theradiag SA announced the appointment of Pierre Morgon as Chairman of the Board of Directors of Theradiag following Board meeting held on October 31, 2018. Pierre Morgon replaces Gérard Tobelem, Chairman of the Board of Directors of Theradiag since 2012, who resigned as Chairman and Director of Theradiag. Pierre Morgon is a member of Theradiag’s Board of Directors since 2012. Pierre A. MORGON, is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Equity Partners. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, of Vaccitech and of Univercells. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies.